Table 5.
Shows sub-group analysis of each scale in Stages 2 & 3 according to participants assessed while ON and OFF medication
| ON Medication |
OFF Medication | |||
|---|---|---|---|---|
| Mean (SD) | 95% CI | Mean (SD) | 95% CI | |
| CB&M Stage 2 | 46.13 (28.87) | 34.47–57.78 | 46.60 (19.97) | 37.25–55.95 |
| CB&M Stage 3 | 20.00 (12.27) | 0.47–39.53 | 14.43 (8.40) | 6.66–22.20 |
| BBS Stage 2 | 45.38 (11.15) | 39.43–51.32 | 46.45 (8.50) | 42.47–50.43 |
| BBS Stage 3 | 35.25 (11.41) | 17.09–53.41 | 29.86 (10.07) | 20.54–39.17 |
| TUG Stage 2 | 11.24 (3.22) | 9.52–12.96 | 12.96 (5.16) | 10.54–15.38 |
| TUG Stage 3 | 15.77 (4.46) | 8.66–22.87 | 22.59 (7.01) | 16.11–29.08 |
| FRT Stage 2 | 22.25 (6.40) | 18.84–25.66 | 20.90 (6.38) | 17.91–23.89 |
| FRT Stage 3 | 16.00 (7.57) | 3.95–28.05 | 12.43 (4.07) | 8.66–16.20 |